The recent announcement by President Donald Trump regarding the imposition of a 25% tariff on all imported goods, including pharmaceuticals, has raised significant concerns within the Canadian pharmaceutical manufacturing industry.
Medication or Drug adherence refers to the extent to which a person’s medication-taking behavior aligns with the recommendations provided by their healthcare provider. Adherence to medications averages around 50% among patients with chronic diseases. This...
A recent report highlights a stark reality faced by cancer patients in Canada: the financial toll of cancer extends far beyond medical treatments. On average, individuals with cancer incur nearly $33,000 in out-of-pocket expenses during...
Melatonin, a popular over-the-counter supplement, is widely used for its sleep-inducing properties. However, its interaction with various medications can lead to significant health risks.
Recent data presented at the American Geriatrics Society (AGS) 2024 Annual Scientific Meeting highlights the widespread use of medications that negatively affect cognition among older adults with dementia. The study analyzed data from approximately 13...
Multiple sclerosis (MS) is a chronic neurological condition that affects the central nervous system (CNS), including the brain and spinal cord. It is characterized by damage to the myelin sheath, the protective covering of nerve...
Do you experience anxiety at the thought of swallowing a whole pill? You're not alone. Many people struggle with swallowing tablets and capsules due to age, medical conditions, or a simple aversion to the size...
Prescription drugs play a vital role in treating and managing various health conditions, but it’s essential to understand them and their mechanisms to ensure optimal health outcomes. In Canada, there are numerous prescription drugs, but...
Off-label use refers to the practice of prescribing a medication for a purpose other than its approved indication. While GLP-1 receptor agonists like Wegovy have been primarily approved for the treatment of diabetes and chronic...
Off-label use refers to the practice of prescribing a medication for a purpose other than its approved indication. While GLP-1 receptor agonists like Wegovy have been primarily approved for the treatment of diabetes and chronic...
